• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室辅助装置植入术后男女患者的心理社会风险与再次住院情况:来自INTERMACS注册研究的多状态分析

Psychosocial Risk and Recurrent Hospitalizations in Women and Men Following LVAD Implantation: A Multi-State Analysis of the INTERMACS Registry.

作者信息

Maukel Lisa-Marie, Schmeller Sandra, Weidner Gerdi, Beyersmann Jan, Spaderna Heike

机构信息

Department of Health Psychology, Trier University, 54296 Trier, Germany.

Institute of Statistics, Ulm University, 89081 Ulm, Germany.

出版信息

J Cardiovasc Dev Dis. 2025 May 22;12(6):198. doi: 10.3390/jcdd12060198.

DOI:10.3390/jcdd12060198
PMID:40558633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193544/
Abstract

BACKGROUND

Women experience higher rates of adverse events and first rehospitalization after left ventricular assist device (LVAD) implantation compared with men. This study investigated the role of sex and preimplant psychosocial risk in recurrent hospitalizations.

METHODS

Data from 20,123 INTERMACS patients (21.3% women) were analyzed. Cumulative transition rates (e.g., home to hospitalization) were estimated and Andersen-Gill models, adjusted for covariates, examined the association between sex, preimplant psychosocial risk, and cumulative transition hazards for rehospitalization. State occupation probabilities, the mean number of hospitalizations, and the cumulative average length of hospital stay were calculated and stratified by sex and psychosocial risk.

RESULTS

Psychosocial risk preimplant was more prevalent in men than in women (21.4% vs. 17.5%, < 0.001). The interaction of female sex and psychosocial risk increased rehospitalization hazards, independently of covariates [HR 1.11, 95% CI (1.01-1.22), = 0.036]. One-year postimplant, women with vs. without psychosocial risk had 2.2 vs. 1.8 hospitalizations, while men experienced 1.8 vs. 1.7 hospitalizations, respectively. Women with vs. without psychosocial risk spent 20 vs.16 days hospitalized, and men 15 vs. 14 days (all < 0.001).

CONCLUSIONS

Preimplant psychosocial risk independently contributed to recurrent hospitalizations post-LVAD, particularly affecting women. The early identification and management of these factors may reduce rehospitalizations and improve clinical outcomes.

摘要

背景

与男性相比,女性在植入左心室辅助装置(LVAD)后发生不良事件和首次再住院的几率更高。本研究调查了性别和植入前心理社会风险在再住院中的作用。

方法

分析了20123例INTERMACS患者(21.3%为女性)的数据。估计累积转移率(如从家到住院),并使用经协变量调整的安德森-吉尔模型,研究性别、植入前心理社会风险与再住院累积转移风险之间的关联。计算状态占用概率、平均住院次数和累积平均住院时间,并按性别和心理社会风险进行分层。

结果

植入前心理社会风险在男性中比在女性中更普遍(21.4%对17.5%,<0.001)。女性性别与心理社会风险的相互作用增加了再住院风险,独立于协变量[风险比1.11,95%置信区间(1.01-1.22),=0.036]。植入后一年,有心理社会风险的女性与无心理社会风险的女性住院次数分别为2.2次和1.8次,而男性分别为1.8次和1.7次。有心理社会风险的女性与无心理社会风险的女性住院时间分别为20天和16天,男性为15天和14天(均<0.001)。

结论

植入前心理社会风险独立导致LVAD植入后再住院,对女性影响尤为明显。对这些因素的早期识别和管理可能会减少再住院次数并改善临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/0b3c0c935912/jcdd-12-00198-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/31bb0fede95a/jcdd-12-00198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/95ebbfeeedf9/jcdd-12-00198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/70933c6a0734/jcdd-12-00198-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/8a60312d06df/jcdd-12-00198-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/aba91ea9d448/jcdd-12-00198-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/0b3c0c935912/jcdd-12-00198-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/31bb0fede95a/jcdd-12-00198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/95ebbfeeedf9/jcdd-12-00198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/70933c6a0734/jcdd-12-00198-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/8a60312d06df/jcdd-12-00198-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/aba91ea9d448/jcdd-12-00198-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b373/12193544/0b3c0c935912/jcdd-12-00198-g006.jpg

相似文献

1
Psychosocial Risk and Recurrent Hospitalizations in Women and Men Following LVAD Implantation: A Multi-State Analysis of the INTERMACS Registry.左心室辅助装置植入术后男女患者的心理社会风险与再次住院情况:来自INTERMACS注册研究的多状态分析
J Cardiovasc Dev Dis. 2025 May 22;12(6):198. doi: 10.3390/jcdd12060198.
2
Evaluation of the ventricular assist device programme in the UK.英国心室辅助装置项目评估
Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480.
3
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry.在全球充血性心力衰竭(G-CHF)注册中心的分析中,来自 40 个不同经济水平国家的充血性心力衰竭女性和男性患者的特征、管理和结局。
Lancet Glob Health. 2024 Mar;12(3):e396-e405. doi: 10.1016/S2214-109X(23)00557-0. Epub 2024 Jan 11.
4
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
5
Gender difference and outcomes in HeartMate 3 left ventricular assist device support: Results from the J-MACS registry.HeartMate 3左心室辅助装置支持中的性别差异与结果:来自J-MACS注册研究的结果
J Cardiol. 2025 Jun 19. doi: 10.1016/j.jjcc.2025.06.010.
6
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.预防产后出血的宫缩剂:一项网状Meta分析
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2.
7
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.针对患有或未患有压力性尿失禁的盆腔器官脱垂女性的手术。
Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013108. doi: 10.1002/14651858.CD013108.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support.对有和没有右心室辅助装置支持的HeartMate 3患者的结局分析。
ESC Heart Fail. 2025 Jun 25. doi: 10.1002/ehf2.15353.
10
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.

本文引用的文献

1
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
2
Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survival.HeartMate 3 植入术后非计划性医院再入院:再入院率、原因及其对生存率的影响。
Artif Organs. 2024 Sep;48(9):1049-1059. doi: 10.1111/aor.14763. Epub 2024 Jun 2.
3
Association of Psychosocial Risk Factors With Quality of Life and Readmissions 1 Year After LVAD Implantation.
左心室辅助装置植入术后1年心理社会风险因素与生活质量及再入院的关联
J Card Fail. 2025 Jan;31(1):40-48. doi: 10.1016/j.cardfail.2024.03.011. Epub 2024 Apr 15.
4
Disparities by Sex, Race, and Ethnicity in Use of Left Ventricular Assist Devices and Heart Transplants Among Patients With Heart Failure With Reduced Ejection Fraction.心力衰竭伴射血分数降低患者中左心室辅助装置和心脏移植在性别、种族和民族方面的差异。
J Am Heart Assoc. 2024 Jan 16;13(2):e031021. doi: 10.1161/JAHA.123.031021. Epub 2024 Jan 3.
5
Comparison of nonparametric estimators of the expected number of recurrent events.比较非参数估计复发事件预期数量的方法。
Pharm Stat. 2024 May-Jun;23(3):339-369. doi: 10.1002/pst.2356. Epub 2023 Dec 28.
6
Sex-based differences in left ventricular assist device clinical outcomes.基于性别的左心室辅助装置临床结局差异。
Catheter Cardiovasc Interv. 2024 Feb;103(2):376-381. doi: 10.1002/ccd.30892. Epub 2023 Oct 23.
7
Adverse events after left ventricular assist device implantation linked to psychosocial risk in women and men.左心室辅助装置植入术后的不良事件与女性和男性的社会心理风险相关。
J Heart Lung Transplant. 2023 Nov;42(11):1557-1568. doi: 10.1016/j.healun.2023.06.013. Epub 2023 Jun 26.
8
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.首次心力衰竭住院后死亡率、结局、成本和药物使用:EVOLUTION HF。
JACC Heart Fail. 2023 Oct;11(10):1320-1332. doi: 10.1016/j.jchf.2023.04.017. Epub 2023 Jun 21.
9
A meta-review of systematic reviews and meta-analyses on outcomes of psychosocial interventions in heart failure.关于心力衰竭心理社会干预结果的系统评价和荟萃分析的元综述。
Front Psychiatry. 2023 Mar 10;14:1095665. doi: 10.3389/fpsyt.2023.1095665. eCollection 2023.
10
Association of Days Alive and Out of the Hospital After Ventricular Assist Device Implantation With Adverse Events and Quality of Life.心室辅助装置植入术后存活天数和出院天数与不良事件及生活质量的关系。
JAMA Surg. 2023 Apr 1;158(4):e228127. doi: 10.1001/jamasurg.2022.8127. Epub 2023 Apr 12.